Indiana 2023 Regular Session Status: Enacted Bipartisan · 8 R · 2 D cosponsors

SB 8 — Prescription drug rebates and pricing.

Last action — Signed by the Governor

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 09, 2023. Enacted.

Prognosis

Likely to advance 78% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 11 sponsors

    4 primary, 7 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (8 R · 2 D) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Requires a pharmacy benefit manager to provide a report to the department of insurance at least every six months. Provides that the report must include the: (1) overall aggregate amount charged to a health plan for all pharmaceutical claims processed by the pharmacy benefit manager; and (2) overall aggregate amount paid to pharmacies for claims processed by the pharmacy benefit manager. Requires that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty.

Bill Text

We don't have the full text on file for this bill yet.

Read SB 8 on the official Indiana source →

Action History

  1. Signed by the Governor

  2. Public Law 166

  3. Signed by the Speaker

  4. Signed by the President of the Senate

  5. Signed by the President Pro Tempore

  6. Senator Johnson removed as coauthor

  7. Rules Suspended. Conference Committee Report 1: adopted by the Senate; Roll Call 525: yeas 40, nays 9

  8. Rules Suspended. Conference Committee Report 1: adopted by the House; Roll Call 550: yeas 72, nays 21

  9. CCR # 1 filed in the House

  10. CCR # 1 filed in the Senate

  11. Representative Schaibley added as conferee

  12. Representative Carbaugh removed as conferee

  13. Representative Schaibley removed as advisor

  14. Senate advisors appointed: Melton and Bohacek

  15. Senate conferees appointed: Charbonneau and Breaux

  16. House advisors appointed: Barrett, Lehman, Schaibley and Porter

  17. House conferees appointed: Carbaugh and Shackleford

  18. Senate dissented from House amendments

  19. Motion to dissent filed

  20. Returned to the Senate with amendments

  21. Third reading: passed; Roll Call 406: yeas 94, nays 0

  22. Second reading: amended, ordered engrossed

  23. Representative Porter added as cosponsor

  24. Amendment #1 (Schaibley) prevailed; voice vote

  25. Committee report: amend do pass, adopted

  26. Representative Olthoff added as cosponsor

  27. First reading: referred to Committee on Insurance

  28. Referred to the House

  29. Cosponsor: Representative Barrett

  30. House sponsor: Representative Schaibley

  31. Third reading: passed; Roll Call 153: yeas 42, nays 5

  32. Senator Randolph added as coauthor

  33. Second reading: amended, ordered engrossed

  34. Amendment #1 (Charbonneau) prevailed; voice vote

  35. Senator Crider added as coauthor

  36. Committee report: do pass, adopted

  37. Senators Donato and Johnson added as coauthors

  38. Senator Busch added as coauthor

  39. Senator Becker added as third author

  40. Senator Bohacek added as second author

  41. First reading: referred to Committee on Health and Provider Services

  42. Authored by Senator Charbonneau

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

4 sponsors · 7 co-sponsors · 139 not signed on

Sponsors (4)

Co-sponsors (7)

Not signed on (139)

139 members have not signed on to this bill.

Show all 139 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 8 do?
Requires a pharmacy benefit manager to provide a report to the department of insurance at least every six months. Provides that the report must include the: (1) overall aggregate amount charged to a health plan for all pharmaceutical claims processed by the pharmacy benefit manager; and (2) overall aggregate amount paid to pharmacies for claims processed by the pharmacy benefit manager. Requires that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty.
Who sponsors SB 8?
SB 8 is sponsored by Gregory Porter (Democrat), Julie Olthoff (Republican), Brad Barrett (Republican), Donna Schaibley, Lonnie Randolph (Democrat), Michael Crider (Republican), Stacey Donato (Republican), Justin Busch (Republican), Vaneta Becker (Republican), Mike Bohacek (Republican), and Ed Charbonneau (Republican).
What is the current status of SB 8?
This bill has been enacted into law. Introduced January 09, 2023. Enacted.
Where can I track SB 8?
Track SB 8 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 8

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 8

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →